Page 10 - Silverstein Foundation News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Gain Therapeutics Presents Positive Preclinical Data on its Small Molecule Lead Compound in GBA1 Parkinson s Disease at XXVII IAPRD World Congress

Press release content from Globe Newswire. The AP news staff was not involved in its creation.

Czech republicEric richmanEuropean union horizonSilverstein foundation for parkinsonGain therapeutics incWorld congress on parkinson diseaseMichaelj fox foundation for parkinson researchRelated disordersChief executive officerManolo bellottoChief strategy officerGlucocerebrosidase shows evidencePharmacological efficacyGain therapeuticsSilverstein foundationMedia contacts

Gain Therapeutics Presents Positive Data on its Structurally Targeted Allosteric Regulators in both Parkinson s and Alzheimer s Disease at the AD/PD 2022 Conference

Gain Therapeutics Presents Positive Data on its Structurally Targeted Allosteric Regulators in both Parkinson s and Alzheimer s Disease at the AD/PD 2022 Conference
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Comunidad autonoma de catalunaJoleen schultzGlucocerebrosidase gcaseEric richmanEuropean union horizonSilverstein foundation for parkinsonGain therapeutics incJoleen schultz associatesInternational conference on alzheimerMichaelj fox foundation for parkinson researchWall streetInternational conferenceChief executive officerManolo bellottoGeneral managerAllosteric regulators

Gain Therapeutics Outlines Key Objectives for

BETHESDA, Md., Feb. 04, 2022 (GLOBE NEWSWIRE) Gain Therapeutics, Inc. (Nasdaq: GANX) (“Gain”, or the “Company”), a biotechnology company transforming.

Joleen schultzEric richmanEuropean union horizonSilverstein foundation for parkinsonGain therapeutics incJoleen schultz associatesHuman research ethics committeeMichaelj fox foundation for parkinson researchAlphafold protein structure databaseGain therapeuticsSilverstein foundationNasdaq ganxGain therapeutics

Gain Therapeutics Progresses Krabbe Disease Program and

Data Show Statistically Significant Increases in GALC Enzyme and Depletion of Toxic Substrate Psychosine.

University of illinoisUnited statesErnestor bongarzoneJoleen schultzEric richmanEuropean union horizonGain therapeutics incJoleen schultz associatesSilverstein foundation for parkinsonCollege of medicineMichaelj fox foundation for parkinson researchChief executive officerGain therapeuticsSilverstein foundationMedia contactsTherapeutics investor contact

Big Day for Four Biopharmas Who Net Millions in Add-on Funds

Big Day for Four Biopharmas Who Net Millions in Add-on Funds
biospace.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from biospace.com Daily Mail and Mail on Sunday newspapers.

United statesUnited kingdomAl iskandariyahVanqua bioJean luc treillouPeter zippeliusLeonard greenLaurent higuerotJonathan silversteinFrederic desddouitsRosana kapellerEli lillyGirish pendseKevin alessandriStevenj kafkaJim trenkle